Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Treatment Indications for Breast Cancer-related Subclinical Lymphedema Identified Through a Bioimpedance Surveillance Model

NCT03292198 is registered in ClinicalTrials.gov with Mercy Research as lead sponsor.

NCT NCT03292198
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03292198 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Treatment Indications for Breast Cancer-related Subclinical Lymphedema Identified Through a Bioimpedance Surveillance Model
Lead sponsor
Mercy Research
Phase
Not applicable
Overall status
Active, not recruiting
Start date
April 1, 2018
Completion date
December 31, 2025
Enrollment
267 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer-related subclinical lymphedema